Incidence, Prevalence, and Mortality of Psychosis Associated with Parkinson's Disease (1991-2010)

被引:11
|
作者
Stang, Cole D. [1 ]
Mullan, Aidan F. [2 ]
Camerucci, Emanuele [1 ]
Hajeb, Mania [1 ]
Turcano, Pierpaolo [3 ]
Martin, Peter [2 ]
Mielke, Michelle M. [2 ]
Josephs, Keith A. [1 ]
Splett, Matthew [4 ]
Abler, Victor [4 ]
Boeve, Bradley F. [1 ]
Bower, James H. [1 ]
Savica, Rodolfo [1 ,2 ]
机构
[1] Mayo Clin, Dept Neurol, 200 First St,SW, Rochester, MN 55905 USA
[2] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA
[3] Mayo Clin, Dept Neurol, Jacksonville, FL 32224 USA
[4] ACADIA Pharmaceut Inc, San Diego, CA USA
关键词
Parkinsonism; psychosis; hallucinations; delirium; antipsychotics; DRUG-INDUCED PSYCHOSIS; RECORDS-LINKAGE SYSTEM; DATA RESOURCE PROFILE; OLMSTED COUNTY; HALLUCINATIONS; POPULATION; CLOZAPINE; QUETIAPINE; SYMPTOMS; DEMENTIA;
D O I
10.3233/JPD-213035
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
BACKGROUND: Parkinson's disease (PD)-associated psychosis is a well-known non-motor complication, occurring years after diagnosis of PD. Incidence data vary across different studies highlighting a need for long-term observation and clinical definition. OBJECTIVE: To determine the incidence of psychosis in patients with PD and to investigate their survival in an incident cohort study from 1991-2010 in Olmsted County, MN. METHODS: We used the Rochester Epidemiology Project to define an incident-cohort study of parkinsonism (1991-2010) in Olmsted County, MN. A movement-disorder specialist reviewed the electronic medical records and applied diagnosis criteria to PD. Psychosis was diagnosed using of NINDS/NIMH unified criteria. RESULTS: We identified 669 cases of parkinsonism; 297 patients were clinically diagnosed with PD. 114/297 (38.4%) patients had evidence of psychosis (60% male); the median onset age of psychosis was 79.4 years. The incidence of Parkinson's disease psychosis (PDP) was 4.28/100 person-years. PDP patients had a 71% increased risk of death compared to PD patients. In PD patients without psychosis, men had 73.4% increased risk of death compared to women, whereas no significant sex difference was observed among PDP men vs. women. Of 114 patients diagnosed with psychosis, 59 were treated with antipsychotics. There was no significant difference in survival between treated and untreated patients. CONCLUSION: PDP increased the odds of death compared to PD patients. Men with PD without psychosis had greater odds of death compared to women; however, in PD with psychosis the odds of death were comparable among sexes. Lastly, treatment with anti-psychotics did not significantly affect survival.
引用
收藏
页码:1319 / 1327
页数:9
相关论文
共 50 条
  • [21] Atypical antipsychotics for Parkinson's disease psychosis: a systematic review and meta-analysis
    Zhang, Han
    Wang, Limin
    Fan, Yafei
    Yang, Lianhong
    Wen, Xiaojun
    Liu, Yunyun
    Liu, Zhonglin
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2019, 15 : 2137 - 2149
  • [22] Screening, Diagnosis, and Management of Parkinson's Disease Psychosis: Recommendations From an Expert Panel
    Pahwa, Rajesh
    Isaacson, Stuart H.
    Small, Gary W.
    Torres-Yaghi, Yasar
    Pagan, Fernando
    Sabbagh, Marwan
    NEUROLOGY AND THERAPY, 2022, 11 (04) : 1571 - 1582
  • [23] Treating Hallucinations and Delusions Associated With Parkinson’s Disease Psychosis
    Shyam C. Panchal
    William G. Ondo
    Current Psychiatry Reports, 2018, 20
  • [24] Psychosis in Parkinson's Disease
    Remz, Matthew
    Salinas, Meagen
    PSYCHIATRIC ANNALS, 2020, 50 (03) : 112 - 119
  • [25] Cannabidiol for the treatment of psychosis in Parkinson's disease
    Zuardi, A. W.
    Crippa, J. A. S.
    Hallak, J. E. C.
    Pinto, J. P.
    Chagas, M. H. N.
    Rodrigues, G. G. R.
    Dursun, S. M.
    Tumas, V.
    JOURNAL OF PSYCHOPHARMACOLOGY, 2009, 23 (08) : 979 - 983
  • [26] Parkinson's disease psychosis
    Jakel, Rebekah J.
    Stacy, Mark
    JOURNAL OF PARKINSONISM AND RESTLESS LEGS SYNDROME, 2014, 4 : 41 - 51
  • [27] Prevalence of Parkinson's Disease-Induced Psychosis in a Large US Managed Care Population
    Holt, R. J.
    Sklar, A. R.
    Darkow, T.
    Goldberg, G. A.
    Johnson, J. C.
    Harley, C. R.
    JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 2010, 22 (01) : 105 - 110
  • [28] Clozapine for Quetiapine-Refractory Psychosis in Parkinson's Disease: A Long-Term Single-Center Retrospective Study
    Pirker, Walter
    PARKINSONS DISEASE, 2025, 2025 (01)
  • [29] Unmet needs in the diagnosis and treatment of Parkinson's disease psychosis and dementia-related psychosis
    Sabbagh, Marwan
    Small, Gary W.
    Isaacson, Stuart H.
    Torres-Yaghi, Yasar
    Pagan, Fernando
    Pahwa, Rajesh
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2023, 27 (01) : 69 - 81
  • [30] Methods of synthesis of Pimavanserin: the first drug approved for the treatment of Parkinson's disease psychosis (PDP)
    Al Bujuq, Nader R.
    ARKIVOC, 2019, : 340 - 352